An interventional study of VRFS in Delirium, sponsored by Peking Union Medical College Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-03-27.
Sponsored by Peking Union Medical College Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Delirium with a site in China — 29 open to participants now, 30 under way, none of them phase 3. Delirium · China.
Among the 96 studies in Delirium with a site in China, this one is the 51st largest by planned enrollment of the 66 interventional ones that give a count, is one of 7 that started in 2023, is one of 40 with no phase, reaches primary completion later than 16 of the 29 other live ones, and was the 61st registered.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →29 of the 96 studies in Delirium with a site in China are open now. Recruiting first, the newest first:
Shanghai Zhongshan Hospital · Sites in China
Ages 18+
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Sites in China
Ages 18–80
Chinese University of Hong Kong · Sites in China
Ages 18+
Beijing Tiantan Hospital · Sites in China
Ages 18–80
China National Center for Cardiovascular Diseases · Sites in China
Ages 18–80
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 7 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 102 is close to the median of 111 across 551 interventional studies indexed under Delirium.
Median enrollment 262 across the 66 interventional studies, 249 across the 30 observational. Of the 42 that completed or were terminated, 5 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 96 have an industry lead sponsor. The 10 most frequent:
Peking Union Medical College Hospital is the lead sponsor of 1,158 studies on the registry; 477 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Peking Union Medical College Hospital has 2 studies filed under Delirium — fewer than ten, so there is no comparison to draw.
8 of the studies in Delirium with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06007755Huazhong University of Science and TechnologyExploring of Serum Biomarkers of Delirium After Cardiovascular Surgery | 2026-12 |
| NCT04832568Huazhong University of Science and TechnologyPerioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery | 2026-12 |
| NCT04091724Huazhong University of Science and TechnologyPerioperative EEG-Monitoring and Emergence Delirium in Children | 2026-12 |
| NCT04789733The Cleveland ClinicThe GUARDIAN Pilot Trial | 2026-12-31 |
| NCT05525702Peking Union Medical College HospitalVR Interventions to Reduce the Prevalence of Delirium in ICU Patients | 2026-12-31 |
Add all 8 to your calendar (.ics) → With an account.
Among the 96 studies in Delirium with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn the effect of Virtual Reality Family Support System (VRFS) on reducing delirium in ICU mechanically ventilated patients. The main question it aims to answer is:
·Using VRFS for participant intervention, can it reduce the incidence of delirium and improve clinical outcomes?
Researchers will investigate whether the implementation of VRFS can reduce the number of delirium days and improve clinical outcomes.
Participants will:
During the VRFS interventions, researchers will fit participants with a VR headset and noise-canceling headphones, shielding them from the ICU environment while allowing family members to be present and offer companionship and comfort.
Inclusion Criteria
Participants will receive standard ICU care and will also undergo VRFS intervention.
Device: VRFS
Patients will be treated with standard ICU care and not receive VR stimulation.
Participants wear VR headsets and experience immersive virtual environments, where their family members will be present and offer companionship and comfort.
Delirium Day
Delirium is monitored and evaluated by the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). The CAM-ICU has four items ((1) altered mental status/fluctuating course, (2)inattention, (3) altered level of consciousness, and (4) disorganized thinking) and each item has two factors (positive or negative). The physicians can diagnose the patients with delirium when the results of item (1), item (2), and item (3) or item (4) are positive.
Time frame: Twice daily from Day 1 through ICU discharge, an average of 7 days.
ICU Days
The ICU stays are daily recorded by the physicians and nurses in ICU.
Time frame: From ICU admission through ICU discharge, an average of 7 days.
Duration of Mechanical Ventilation
The duration of mechanical ventilation is daily recorded by the physicians and nurses.
Time frame: From the start of mechanical ventilation through endotracheal tube (ETT) removal, an average of 6 days.
Dosage of sedative and analgesic drugs
Daily records by doctors and nurses.
Time frame: Daily from Day 1 through ICU discharge, an average of 7 days.
Incidence of Delirium
The proportion of participants who experience at least one CAM-ICU-positive episode during their ICU stay, assessed twice daily using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).
Time frame: Twice daily from Day 1 through ICU discharge, an average of 7 days.
Family Satisfaction with Care in the Intensive Care Unit (FS-ICU)
Family satisfaction is assessed using the FS-ICU scale, evaluating satisfaction with nursing care (FS-Care) and the decision-making process (FS-DM). The results include the total score (FS-Total) and two subscale scores (FS-Care and FS-DM).
Time frame: At baseline (Day 0) and within 3 days after ICU discharge.
Electroencephalogram (EEG)
A wearable headset device was utilized to obtain consistent and adequate quality EEG data.
Time frame: At baseline (Day 0) and within 3 days after ICU discharge.
Oxygen saturation level
The oxygen saturation level (SpO2, %) will be collected from a bedside monitor before the intervention.
Time frame: At baseline (Day 0) and within 3 days after ICU discharge.
Blood pressure
The blood pressure(mmHg) will be collected from a bedside monitor after the intervention. Both Systolic and Diastolic Blood Pressure will be measured.
Time frame: At baseline (Day 0) and within 3 days after ICU discharge.
Plan to share: No
Started Dec 2023 (actual). Primary completion is estimated for Dec 2026, 36 months after the start.
Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 36 months is above that.
Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking Union Medical College Hospital →